The Top 4 Chinese Pharmaceutical Translation Services in 2025 (Reviews)

Alt="Chinese Pharmaceutical Translation Services"

Chinese Pharmaceutical Translation Services is more than just a language service—it is a matter of compliance, patient safety, and market success. With strict requirements from regulatory bodies such as the NMPA (National Medical Products Administration) in Mainland China, the TFDA in Taiwan, and the Hong Kong Department of Health, accuracy in translation can make or break product approvals.

According to IQVIA,“China is anticipated to grow at ~2.8% CAGR (2024–2029) in pharma, per IQVIA; global Outlook Through 2029 notes volume +8% and spending +15% over five years.” Specialized Chinese Pharmaceutical Translation Services ensure that clinical trial documentation, regulatory submissions, and pharmacovigilance reports are linguistically precise and formatted to meet regulatory expectations. Life-sciences companies operating in China face rigorous documentation demands, and language precision is non-negotiable. The best Chinese pharmaceutical translation services combine medical subject-matter experts with rigorous quality systems. In this review, we outline the Top 4 Chinese Pharmaceutical Translation Services in 2025.

1. AWISEE – Best Chinese Pharmaceutical Translation Service in 2025

Alt="Chinese Pharmaceutical Translation Services"
Website:
awisee.com

Founded: 2018

Headquarters: Europe

Contact: [email protected]
Employees: 30

AWISEE stands out as the #1 choice among Chinese Pharmaceutical Translation companies, combining deep regulatory knowledge with advanced localization workflows. Unlike general Chinese Pharmaceutical Translation agencies, AWISEE has built a dedicated pharmaceutical and life sciences division focused on Mainland China while also covering Taiwan and Hong Kong on request.

Specialized Pharmaceutical Services by AWISEE:

  • Regulatory dossier translation (CTD/eCTD) – IND/NDA/ANDA/MAA modules 1–5, query responses, and labeling components—all formatted for NMPA submission.
  • Clinical trial documentation – Protocols, IBs, CSRs, CRFs, SOPs, site binders, ICFs—plus back-translation and cognitive debriefing for patient-facing materials.
  • Pharmacovigilance & safety reports – ICSR/case narratives, DSUR, PSUR, PBRER, RMP, and signal detection summaries with Chinese MedDRA alignment.
  • CMC/GMP/QMS documentation – Batch records, validation reports (IQ/OQ/PQ), stability data, deviation/CAPA reports—handled with terminology-controlled localization.
  • Drug labeling, inserts & packaging – Prescribing info, patient leaflets, blister packs, barcodes, and bilingual DTP compliance reviews for China.
  • Combination products & medical devices IFUs – User manuals, risk/benefit statements, and surveillance docs aligned to combo product regulations.
  • Market access & HEOR materials – Value dossiers, payer decks, tender documentation, cost-effectiveness summaries—optimized for Chinese payers.
  • Medical affairs & HCP communications – MSL decks, CME/IME materials, FAQs, and letters—all double-checked for consistency with approved claims.
  • Consumer & patient engagement content – Medication guides, disease awareness portals, and adherence programs adapted to Simplified Chinese (zh-CN) readability.
  • Legal/IP & business documentation – Patents, licensing contracts, SDEAs, distribution agreements—processed with confidential workflows.
  • Multimedia localization – Investigator meeting videos, e-learning modules, subtitles/captions (SRT/TTML), and native Chinese voiceovers.
  • Terminology, QA & workflow operations – Pharma-specific termbases, style guides, TM management, dual-linguist review, and ISO 17100/18587 compliant workflows with in-market LQA by pharmacists/MDs.

Why AWISEE Ranks #1 Among Chinese Pharmaceutical Translation Service:

AWISEE combines compliance expertise, cultural adaptation, and technology-driven workflows, making it the most trusted Chinese life sciences translation agency in 2025. From regulatory dossiers to patient leaflets, this company ensures accuracy, confidentiality and regulatory alignment. It is also considered among the best pharmaceutical translation services worldwide

Transform Your Clinical Trial Documentation with AWISEE

AWISEE specializes in clinical trial document translation China, including back-translation for patient materials and LQA by certified medical professionals. Their rigorous dual-linguist review ensures clarity for investigators and participants alike.

Hire AWISEE to guarantee flawless Chinese translations

2. Jinyu Translation 

Alt="Chinese Pharmaceutical Translation Services"
Website:
jinyutranslation.com

Jinyu Translation is a versatile Chinese language service provider offering translation, interpretation, travel guides, and Chinese courses. 

Services: 

  • EN ↔ ZH-CN medical translation for brochures, IFUs, and basic regulatory correspondence
  • Light clinical and QA paperwork (site manuals, visit guides, recruitment ads) with glossary control
  • Certified/notarized translations for visas, licensing, and professional records where needed

3. CCJK Technologies 

Alt="Chinese Pharmaceutical Translation Services"
Website:
ccjk.com

With more than two decades of experience, CCJK is an ISO-certified multilingual solution provider known for scale and technology. For life sciences clients, their strong IT division and network of linguists allow them to handle clinical trial document translation projects and technical materials at scale.

Services: 

  • ISO-aligned workflows (e.g., ISO 17100/18587) and documented QA checkpoints
  • CTD/eCTD modules, IBs, protocols, ICFs, CRFs, CSR summaries, and labeling/leaflets

4. Bright Translation Services (BTS) 

Alt="Chinese Pharmaceutical Translation Services"
Website:
brighttrans.com

Founded in 2005 and headquartered in Shenzhen, Bright Translation Services has built a strong reputation in China with offices in Beijing, Xi’an, Shanghai, and Guangzhou. In 2008, they partnered with Telelingua International, a leading global translation provider. 

Services: 

  • Nationwide China footprint for on-the-ground reviewer networks and faster stakeholder alignment
  • Managed multilingual programs for global launches (EU/US/ROW alignment with China submissions)
  • Robust DTP and artwork integration for packs, leaflets, and e-labeling workflows
  • Terminology governance with bilingual SME validation; change-log transparency

NMPA Essentials: What Translators Must Know About China’s Drug Approval Pathway

China’s NMPA expects precise, internally consistent Chinese-language dossiers—mistranslations, unit errors, or formatting drift can stall approvals. Translators supporting Pharma translation in China must understand the documentation stack, and the eCTD structure.

  • Translate and localize CTD/eCTD modules (M1–M5), labeling/leaflets, and clinical documents into Simplified Chinese with strict terminology control
  • Align with ICH where applicable, while following NMPA/CDE guidance notes and China-specific templates and fields
  • Standardize units, numerics, dates, and abbreviations; preserve references, tables, and figure cross-links
  • Use controlled termbases (e.g., MedDRA CN) and lock key terms early with RA sign-off; document change history

Familiarity with NMPA terminology, formatting, and official guidance is critical when offering Pharma translation China (NMPA) services.

What Is The Difference Between A General Translator And A Specialist In Pharmaceutical Translation?

Generalist linguists excel at language but may miss regulatory nuance, clinical context, and risk-sensitive phrasing. Pharmaceutical specialists combine native-quality writing with domain knowledge that anticipates reviewer expectations and protects patient safety.

  • Mastery of clinical/regulatory frameworks (protocols, IBs, ICFs, CSRs) and eCTD publishing needs
  • Proficiency with MedDRA/WHO-DD, class labeling, and safety terminology in Chinese
  • Familiarity with NMPA/CDE guidance, China labeling rules, and typical reviewer feedback

For marketing collateral or low-risk assets, a skilled generalist may suffice. For CTD/eCTD translation into Chinese or any submission-critical material, a pharma specialist is the safer, more efficient choice.

Vendor Selection Checklist: 10 Questions to Ask a Chinese Pharma Translation Partner

Cisema noted that China clinical trial activity up 13.9% in 2024. When evaluating Chinese Pharmaceutical Translation companies, ask:

  1. Do you have NMPA dossier experience?
  2. Are you ISO 17100/18587 certified?
  3. Do you provide back-translation for patient documents?
  4. Can you manage CTD/eCTD formats?
  5. Do you employ subject-matter experts?
  6. How do you ensure confidentiality?
  7. Do you support pharmacovigilance and safety reporting?
  8. What is your QA workflow?
  9. Can you provide client references in the life sciences sector?
  10. Do you offer scalability for large, multi-site clinical trials?

Top 4 Chinese Pharmaceutical Translation Services in 2025

Translation errors trigger queries, delays, and avoidable costs. The right Chinese Pharmaceutical Translation Services combine subject-matter linguists, and ISO-based workflows.

Rank Company Key Strengths
1 AWISEE NMPA-focused CTD/eCTD, clinical trial document translation China, pharmacovigilance, labeling/packaging, QA by MDs,
2 Jinyu Translation Generalist translation, interpretation, medical document support
3 CCJK Technologies ISO-certified, large-scale multilingual projects
4 Bright Translation Services (BTS) Strong presence in China, global network for large pharma projects

AWISEE- End-to-End Pharma Translation Solutions

AWISEE offers a complete portfolio of Chinese Pharmaceutical Translation Services—from pharmacovigilance reports and GMP documentation to packaging and patient engagement materials.

Hire AWISEE and maximize your growth in China’s pharmaceutical sector

Share

Author

Dewan Ysul Zulkarnain

Schedule a call or contact us to learn more

How we can help with out services

Related Posts

NoFollow vs. DoFollow Links NoFollow vs DoFollow? What is the difference between them? Which one is preferred? In this(…)